Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer [Phase 1]
A Phase 1 study evaluated intravenous aflibercept in combination with FOLFIRI in Japanese patients with metastatic colorectal cancer and has…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Online Programs to Promote Colon Cancer Screening [NA]
This entry reports the completion of a clinical trial evaluating online programs to promote colorectal cancer screening. The study examined …
-
CLINICAL_TRIALS research · 2012-11-08Clinical Trial Update: PeerScope B System™ Clinical Protocol [NA]
The PeerScope B System™ clinical protocol has completed. The update notes a completed protocol evaluating a device for colorectal conditions…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer [Phase 2]
Phase II trial evaluating irinotecan, S-1, and bevacizumab for unresectable or recurrent colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) [Phase 2]
Phase II trial evaluating bevacizumab plus S-1 in elderly patients with unresectable or recurrent colorectal cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer [Phase 2]
Phase II trial update of the combination therapy S-1, irinotecan, and bevacizumab (SIRB) in patients with unresectable or recurrent colorect…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer [Phase 2, Phase 3]
A completed Phase II/III randomized trial compared irinotecan-based regimens (irinotecan + 5-FU + leucovorin) versus irinotecan + TS-1 as se…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer [Phase 1]
This is a completed Phase 1 trial evaluating a combination of everolimus (RAD001), cetuximab, and irinotecan as second-line therapy for meta…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer [Phase 2]
This document reports the completion of a randomized Phase II trial of SOL in untreated metastatic colorectal cancer, sponsored by Taiho Pha…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating Cediranib (RECENTIN) in combination with chemotherapy for untreated metastatic colorectal cancer has completed, wit…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial of ZD 1839 (gefitinib) in locally advanced or metastatic colorectal cancer completed.
-
CLINICAL_TRIALS research · 2012-10-26Clinical Trial Update: A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer [Phase 3]
This clinical trial update describes a Phase III study comparing UFT+PSK versus UFT+LV in stage IIB and stage III colorectal cancer. The cur…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating surgery with or without thalidomide in patients with recurrent or metastatic colorectal cancer was terminated, an…
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) [Phase 2]
Phase 2 trial update evaluating a second-line therapy added to the FOLFOX regimen in colorectal cancer; results were posted in 2012.
-
CLINICAL_TRIALS research · 2012-10-24Clinical Trial Update: Quantifying Micro RNA Levels of Colon
A clinical trial update investigating microRNA levels in colorectal cancer patients to evaluate their potential as biomarkers.
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer [Phase 4]
This clinical trial update reports a Phase 4 study evaluating cetuximab in combination with chemotherapy for metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal Surgery [NA]
A completed clinical trial evaluated whether intravenous lidocaine influences tolerability of early oral feeding after laparoscopic colorect…
-
CLINICAL_TRIALS research · 2012-10-16Clinical Trial Update: The Investigation of the EtCO₂- PaCO₂ Relation During Laparoscopic Colon Surgery
Update on a clinical trial examining the relationship between end-tidal CO2 and arterial CO2 during laparoscopic colon surgery in colorectal…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer [Phase 2]
A Phase 2 randomized study comparing Sunitinib plus FOLFOX versus Bevacizumab plus FOLFOX in metastatic colorectal cancer was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer [Phase 2]
Phase 2 clinical trial comparing oxaliplatin with S-1 versus oxaliplatin with capecitabine for advanced colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery [Phase 4]
Phase 4 clinical trial evaluating medium calorie parenteral nutrition in patients with colorectal cancer undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer [Phase 1]
Phase 1 study evaluating the safety and tolerability of the combination of vandetanib (ZD6474), cetuximab, and irinotecan in patients with m…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen [Phase 3]
This Phase 3 trial evaluated aflibercept plus irinotecan and 5-FU versus placebo plus irinotecan and 5-FU in patients with metastatic colore…
-
FDA approval · 2012-09-27FDA Approved: STIVARGA — Original Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved STIVARGA (regorafenib) based on Bayer's original application for patients with metastatic colorectal cancer who have progre…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer [NA]
Completed clinical trial evaluating lymphatic mapping and sentinel lymph node biopsy in colorectal cancer to evaluate surgical staging techn…